Legal & General Group PLC Acer Therapeutics Inc. Transaction History

Legal & General Group PLC

  • $440 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$1.53 - $4.53 $2,184 - $6,468
-1,428 Closed
0 $0
Q1 2020

May 14, 2020
BUY
$1.18 - $5.86 $1,460 - $7,254
1,238 Added 651.58%
1,428 $3,000
Q4 2019

Feb 13, 2020
BUY
$2.85 - $4.2 $541 - $798
190 New
190 $1,000

Others Institutions Holding ACER

# of Institutions
1
Shares Held
365
Call Options Held
0
Put Options Held
0
View Full List

About Acer Therapeutics Inc.

ACER Quotes by TradingView
  • Ticker ACER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,100,000
  • Description
  • Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...
More about ACER
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email